TY - JOUR
T1 - Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction
T2 - The Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial
AU - Lam, Carolyn S P
AU - Carson, Peter E.
AU - Anand, Inder S.
AU - Rector, Thomas S.
AU - Kuskowski, Michael
AU - Komajda, Michel
AU - McKelvie, Robert S.
AU - McMurray, John J.
AU - Zile, Michael R.
AU - Massie, Barry M.
AU - Kitzman, Dalane W.
PY - 2012/9
Y1 - 2012/9
N2 - Background: There are few sex-specific outcome data in heart failure with preserved ejection fraction. Methods and Results: We assessed sex differences in baseline characteristics and outcomes among 4128 patients with heart failure with preserved ejection fraction in the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Women (n=2491) with heart failure with preserved ejection fraction were ≈1 year older (72±7 years versus 71±7 years) and more likely to be obese (46% versus 35%) and have chronic kidney disease (34% versus 26%) and hypertension (91% versus 85%) than men but less likely to have an ischemic cause (19% versus 34%), atrial fibrillation (27% versus 33%), or chronic obstructive pulmonary disease (8% versus 13%) (all P <0.001). During a mean of 49.5 months, there were 881 deaths (447 in women, 434 in men; risk ratio, 0.64;95% CI, 0.56-0.74) and 5776 hospitalizations (3239 in women, 2537 in men; risk ratio, 0.80;95% CI, 0.76-0.84). Women had lower risk of all-cause events (deaths and hospitalizations), even after adjusting for baseline characteristics (adjusted hazards ratio, 0.81;95% CI, 0.73-0.89). However, the sex-related difference in risk of all-cause events was modifed in the presence or absence of atrial fibrillation, renal dysfiunction, stable angina pectoris, or advanced New York Heart Association class symptoms. Conclusions: In patients with typical heart failure with preserved ejection fraction, there were prominent sex differences in baseline characteristics and outcomes. Women had better overall prognosis, although the presence of 4 common baseline characteristics seemed to moderate this finding. Clinical Trial Registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT000095238.
AB - Background: There are few sex-specific outcome data in heart failure with preserved ejection fraction. Methods and Results: We assessed sex differences in baseline characteristics and outcomes among 4128 patients with heart failure with preserved ejection fraction in the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Women (n=2491) with heart failure with preserved ejection fraction were ≈1 year older (72±7 years versus 71±7 years) and more likely to be obese (46% versus 35%) and have chronic kidney disease (34% versus 26%) and hypertension (91% versus 85%) than men but less likely to have an ischemic cause (19% versus 34%), atrial fibrillation (27% versus 33%), or chronic obstructive pulmonary disease (8% versus 13%) (all P <0.001). During a mean of 49.5 months, there were 881 deaths (447 in women, 434 in men; risk ratio, 0.64;95% CI, 0.56-0.74) and 5776 hospitalizations (3239 in women, 2537 in men; risk ratio, 0.80;95% CI, 0.76-0.84). Women had lower risk of all-cause events (deaths and hospitalizations), even after adjusting for baseline characteristics (adjusted hazards ratio, 0.81;95% CI, 0.73-0.89). However, the sex-related difference in risk of all-cause events was modifed in the presence or absence of atrial fibrillation, renal dysfiunction, stable angina pectoris, or advanced New York Heart Association class symptoms. Conclusions: In patients with typical heart failure with preserved ejection fraction, there were prominent sex differences in baseline characteristics and outcomes. Women had better overall prognosis, although the presence of 4 common baseline characteristics seemed to moderate this finding. Clinical Trial Registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT000095238.
KW - Aging
KW - Heart failure
KW - Preserved left ventricular function
KW - Prognosis
KW - Sex
UR - http://www.scopus.com/inward/record.url?scp=84868666984&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84868666984&partnerID=8YFLogxK
U2 - 10.1161/CIRCHEARTFAILURE.112.970061
DO - 10.1161/CIRCHEARTFAILURE.112.970061
M3 - Article
C2 - 22887722
AN - SCOPUS:84868666984
SN - 1941-3289
VL - 5
SP - 571
EP - 578
JO - Circulation: Heart Failure
JF - Circulation: Heart Failure
IS - 5
ER -